Literature DB >> 25658549

Regional distribution of nosocomial infections due to ESBL-positive Enterobacteriaceae in Germany: data from the German National Reference Center for the Surveillance of Nosocomial Infections (KISS).

R Leistner1, C Schröder2, C Geffers2, A-C Breier2, P Gastmeier2, M Behnke2.   

Abstract

Surveillance systems for hospital infections are reporting increasing rates of extended-spectrum β-lactamase (ESBL)-positive Enterobacteriaceae in Europe. We aimed to perform a national survey on this trend and on the regional distribution of nosocomial infections due to ESBL-positive Enterobacteriaceae in German hospitals. Data from 2007 to 2012 from two components of the German national nosocomial infection surveillance system were used for this analysis. The data derive from intensive care units and surgical departments. Independent factors determining the proportion of ESBL-positive Enterobacteriaceae among nosocomial infections due to Enterobacteriaceae and changes in its regional distribution (broken down into German federal states) were calculated by regression analysis. From 2007 to 2012, the data showed a significantly increasing proportion of ESBL-positive Enterobacteriaceae in surgical site infections (from 11.46 to 15.38, 134%, p 0.003), urinary tract infections (9.36 to 16.56, 177%, p <0.001) and lower respiratory tract infections (11.91 to 14.70, 123%, p <0.001) due to Enterobacteriaceae. Factors independently associated with a growing proportion were: Thuringia (p 0.009; odds ratio (OR) 1.53), North Rhine-Westphalia (p <0.001; OR 1.41) and general surgery ward (p 0.002; OR 1.47). The proportion of ESBL-positive Enterobacteriaceae in nosocomial infections has significantly increased in Germany over the last 6 years. Hospitals in Central Germany and surgical departments in all of Germany are especially affected by this development.
Copyright © 2014 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Extended-spectrum β-lactamase; healthcare associated; hospital epidemiology; nosocomial infection; surveillance system

Mesh:

Substances:

Year:  2014        PMID: 25658549     DOI: 10.1016/j.cmi.2014.07.015

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  10 in total

1.  E. coli bacteremia in comparison to K. pneumoniae bacteremia: influence of pathogen species and ESBL production on 7-day mortality.

Authors:  R Leistner; A Bloch; P Gastmeier; F Schwab
Journal:  Antimicrob Resist Infect Control       Date:  2016-10-19       Impact factor: 4.887

2.  Antibiotic-Resistant Extended Spectrum ß-Lactamase- and Plasmid-Mediated AmpC-Producing Enterobacteriaceae Isolated from Retail Food Products and the Pearl River in Guangzhou, China.

Authors:  Qinghua Ye; Qingping Wu; Shuhong Zhang; Jumei Zhang; Guangzhu Yang; Huixian Wang; Jiahui Huang; Mongtong Chen; Liang Xue; Juan Wang
Journal:  Front Microbiol       Date:  2017-02-03       Impact factor: 5.640

3.  Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients.

Authors:  Hui Zhang; Qiwen Yang; Kang Liao; Yuxing Ni; Yunsong Yu; Bijie Hu; Ziyong Sun; Wenxiang Huang; Yong Wang; Anhua Wu; Xianju Feng; Yanping Luo; Yunzhuo Chu; Shulan Chen; Bin Cao; Jianrong Su; Qiong Duan; Shufang Zhang; Haifeng Shao; Haishen Kong; Bingdong Gui; Zhidong Hu; Robert Badal; Yingchun Xu
Journal:  BMC Infect Dis       Date:  2017-12-18       Impact factor: 3.090

4.  Current status of postoperative infections after digestive surgery in Japan: The Japan Postoperative Infectious Complications Survey in 2015.

Authors:  Toru Niitsuma; Shinya Kusachi; Yoshio Takesue; Hiroshige Mikamo; Koji Asai; Manabu Watanabe
Journal:  Ann Gastroenterol Surg       Date:  2019-03-12

5.  Trend in Antibiotic Resistance of Extended-Spectrum Beta-Lactamase-Producing Escherichia Coli and Klebsiella Pneumoniae Bloodstream Infections.

Authors:  Banu Bayraktar; Süleyman Pelit; Mehmet Emin Bulut; Elif Aktaş
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2019-03-25

Review 6.  Prevalence of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Ethiopia: A Systematic Review and Meta-Analysis.

Authors:  Teklehaimanot Kiros; Lema Workineh; Tegenaw Tiruneh; Tahir Eyayu; Shewaneh Damtie; Debaka Belete
Journal:  Int J Microbiol       Date:  2021-03-31

Review 7.  Meta-analysis of proportion estimates of Extended-Spectrum-Beta-Lactamase-producing Enterobacteriaceae in East Africa hospitals.

Authors:  Tolbert Sonda; Happiness Kumburu; Marco van Zwetselaar; Michael Alifrangis; Ole Lund; Gibson Kibiki; Frank M Aarestrup
Journal:  Antimicrob Resist Infect Control       Date:  2016-05-14       Impact factor: 4.887

8.  Prevalence of extended-spectrum-β-lactamase-producing Enterobacteriaceae: first systematic meta-analysis report from Pakistan.

Authors:  Samyyia Abrar; Shahida Hussain; Rehan Ahmad Khan; Noor Ul Ain; Hayat Haider; Saba Riaz
Journal:  Antimicrob Resist Infect Control       Date:  2018-02-20       Impact factor: 4.887

9.  Does inappropriate initial antibiotic therapy affect in-hospital mortality of patients in the emergency department with Escherichia coli and Klebsiella pneumoniae bloodstream infections?

Authors:  Fu-Cheng Chen; Yu-Ni Ho; Hsien-Hung Cheng; Chien-Hung Wu; Meng-Wei Change; Chih-Min Su
Journal:  Int J Immunopathol Pharmacol       Date:  2020 Jan-Dec       Impact factor: 3.219

10.  Incidence of infections due to third generation cephalosporin-resistant Enterobacteriaceae - a prospective multicentre cohort study in six German university hospitals.

Authors:  Anna M Rohde; Janine Zweigner; Miriam Wiese-Posselt; Frank Schwab; Michael Behnke; Axel Kola; Birgit Obermann; Johannes K-M Knobloch; Susanne Feihl; Christiane Querbach; Friedemann Gebhardt; Alexander Mischnik; Vera Ihle; Wiebke Schröder; Sabina Armean; Silke Peter; Evelina Tacconelli; Axel Hamprecht; Harald Seifert; Maria J G T Vehreschild; Winfried V Kern; Petra Gastmeier
Journal:  Antimicrob Resist Infect Control       Date:  2018-12-27       Impact factor: 4.887

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.